NPM–ALK can also lead to ALCL development in T-lymphoid subsets other than TCRαβ precursors, as 19% of human cases expressed a uniform TCRγδ immunogenetic profile, with thymic type Vδ1-Jδ1 rearrangements30. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.